Exhibit 107
Calculation of Filing Fee Table
Form S-8
(Form Type)
Aptose Biosciences Inc.
(Exact Name of Registrant as Specified in its Charter)
Table 1: Newly Registered Securities
| Security Type | Security Class Title | Fee Calculation Rule | Amount Registered(1) | Proposed Maximum Offering Price Per Unit | Proposed Maximum Aggregate Offering Price | Fee Rate | Amount of Registration Fee | ||||
| Equity | Common Shares, without par value, issuable under the Aptose Biosciences Inc. 2021 Stock Incentive Plan, as amended | Other | 68,517 (2) | $3.305(3) | $226,448.685(3) | 0.00011020 | $ | 24.95 | |||
| Total Offering Amounts | $ | 226,448.685 | $ | 24.95 | |||||||
| Total Fee Offsets | - | ||||||||||
| Net Fee Due | $ | 24.95 | |||||||||
| (1) | In accordance with Rule 416 under the Securities Act of 1933, as amended (the “Securities Act”), this registration statement shall be deemed to cover any additional securities that may from time to time be offered or issued to prevent dilution resulting from stock splits, stock dividends or similar transactions. |
| (2) | Represents 68,517 additional common shares, without par value (the “Common Shares”), of Aptose Biosciences Inc. (the “Registrant”) available for issuance under the Aptose Biosciences Inc. 2021 Stock Incentive Plan (the “2021 Plan”). |
| (3) | Estimated solely for the purpose of calculating the registration fee under Rule 457(c) and (h) of the Securities Act on the basis of the average of the high and low sales price per Common Share on September 20, 2023, as reported on the Nasdaq Capital Market. |
